TODAY marks the new PBS availability of Zeposia (ozanimod) from Celgene, a once-daily oral selective sphingosine-1-phosphate recceptor modulator for adults with moderately-to-severely active ulcerative colitis.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 May 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 May 23
Warning: Undefined variable $o_shortcode_atts in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1263
Warning: Undefined variable $output in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1266
